Dear Core User,
Due to the current situation with COVID-19, per directives from Senior management at Partners and the Hospitals, this research core facilities will have a hiatus in their service offering. We will not be offering service till we are advised to resume operation.
Please stay safe in this challenging time and we look forward to working with you in the future.
Gene Transfer Vector Core
Due to a COVID-19 related shut-down of research activities within the Partners system, the Gene Transfer Vector Core (GTVC) at MEE has brought all activities to a safe stopping point on 3/18/2020. Activities will resume at a future point as per institutional guidelines and will be reported here. GTVC will, therefore, be unable to provide services at this point. However, we will continue taking novel orders (Please fill out the Service Request for submitting your order).
Inquiries can be directed as usual to firstname.lastname@example.org
Thank you for your understanding and apologies for the delays this may cause in your research program.
The Gene Transfer Vector Core (GTVC) is a viral vector core facility located at the Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, both affiliated with Harvard Medical School. GTVC is an integral part of the Grousbeck Gene Therapy Center and the Ocular Genomics Institute of Harvard Medical School and Massachusetts Eye and Ear Infirmary.
Our primary goal is to provide high titer, high quality research-grade viral vectors to the research community at Harvard, within Boston, and outside to support preclinical gene therapy studies and basic research gene transfer applications.
Our Services Include:
- High titer, high quality research-grade Adeno-Associated viruses (AAV).
- Production of customized vectors at different scales.
- Inventory of ready-made reporter and commonly used gene vectors.
- Consultation & assistance application-specific vector design.
- Plasmid cloning and purification support services
- High-quality full sequence analysis of source material